Treatment
-
Misunderstandings About Cancer DNA Tests
Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.
by Emma Yasinski
-
September 27: The Week in Cancer News
A study examines how poor and minority patients are more likely to be diagnosed with cancer in the emergency room, and a cancer survivor considers the lasting effects of chemotherapy.
by Bradley Jones
-
Forward Look
Measuring Treatment EffectivenessOutcomes are often evaluated using progression-free survival.
by Jasenka Piljac Zegarac
-
Forward Look
New Option for Treating Pain From Bone MetastasesStudy supports use of single-session, higher-dose radiation.
by Jane Langille
-
Finding More Targets for CAR-T Cells
CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.
by Kendall K. Morgan
-
Q&A
The Promise of CRISPRBiochemist Samuel H. Sternberg describes the limitations, realities and potential of gene-editing technology.
by Marci A. Landsmann
-
September 13: The Week in Cancer News
Some cancer drugs being tested in clinical trials do not work the way researchers thought they did, and ringing a bell following radiation therapy may increase distress for patients.
by Kate Yandell
-
HIV Can Worsen Cancer Treatment Outcomes
People with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.
by Jon Kelvey
-
Immunotherapy in the Elderly
Immune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.
by Emma Yasinski
-
Proton Therapy Is Associated With Reduced Side Effects
When combined with chemotherapy, the newer form of radiation comes with fewer severe side effects than standard radiation therapy, a study suggests.
by Sue Rochman